Cargando…

The Differentiation Syndrome in Patients with Acute Promyelocytic Leukemia: Experience of the Pethema Group and Review of the Literature

Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is the main life-threatening complication of therapy with differentiating agents (all-trans retinoic acid [ATRA] or arsenic trioxide [ATO]) in patients with acute promyelocytic leukemia (APL). The differentiation of leukemic bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montesinos, Pau, Sanz, Miguel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2011
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248336/ https://www.ncbi.nlm.nih.gov/pubmed/22220256 http://dx.doi.org/10.4084/MJHID.2011.059

Ejemplares similares

PLZF-RAR(α), NPM1-RAR(α), and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review
por: Sobas, Marta, et al.
Publicado: (2020)

Acute Promyelocytic Leukemia during Pregnancy: A Systematic Review of the Literature
por: Santolaria, Andrea, et al.
Publicado: (2020)

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLASMS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: THE PETHEMA-PALG EXPERIENCE.
por: Sobas, Marta, et al.
Publicado: (2023)

Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
por: Sanz, Jaime, et al.
Publicado: (2021)

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
por: Labrador, Jorge, et al.
Publicado: (2022)

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry
por: Martínez, Pilar, et al.
Publicado: (2020)

No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group
por: Castaño-Bonilla, Tamara, et al.
Publicado: (2022)

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
por: Labrador, Jorge, et al.
Publicado: (2022)

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
por: Sargas, Claudia, et al.
Publicado: (2020)

History of Acute Promyelocytic Leukemia
por: Sanz, Miguel A., et al.
Publicado: (2021)

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
por: Sargas, Claudia, et al.
Publicado: (2023)

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
por: Martínez-Cuadrón, David, et al.
Publicado: (2022)

Differentiation syndrome in patients with acute promyelocytic leukemia
por: Elamin, Nusiba H., et al.
Publicado: (2023)

The feasibility of PETHEMA ALL-96 regimen on treatment of patients with acute lymphoid leukemia
por: Ashrafi, Farzaneh, et al.
Publicado: (2023)

Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups
por: Ribera, Josep-Maria, et al.
Publicado: (2020)

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
por: Martínez-Cuadrón, David, et al.
Publicado: (2022)

Single-Nucleotide Polymorphism Array-Based Karyotyping of Acute Promyelocytic Leukemia
por: Gómez-Seguí, Inés, et al.
Publicado: (2014)

Bronchoalveolar lavage fluid review in acute promyelocytic leukemia differentiation syndrome
por: Seifert, Robert P., et al.
Publicado: (2021)

Acute promyelocytic leukemia (APL): a review of the literature
por: Jimenez, Joaquin J., et al.
Publicado: (2020)

Pancreatitis in Acute Promyelocytic Leukemia: Drug-induced or Differentiation Syndrome?
por: De, Dibyendu, et al.
Publicado: (2017)

A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
por: Ribera, Josep‐Maria, et al.
Publicado: (2020)

Nephrotic syndrome in acute promyelocytic leukemia
por: Moradveisi, Borhan, et al.
Publicado: (2014)

The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations
por: Ibáñez, Mariam, et al.
Publicado: (2016)

Late Differentiation Syndrome in Acute Promyelocytic Leukemia: A Challenging Diagnosis
por: Cabral, Renata, et al.
Publicado: (2014)

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
por: LaBella, Dominic, et al.
Publicado: (2022)

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
por: Ayala, Rosa, et al.
Publicado: (2021)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Acute Promyelocytic Leukemia and HIV: Case Reports and a Review of the Literature
por: Kunitomi, Akane, et al.
Publicado: (2019)

Acute promyelocytic leukemia with myelofibrosis: A case report and literature review
por: Xiao, Mengyu, et al.
Publicado: (2021)

Differentiation Syndrome, a Side Effect From the Therapy of Acute Promyelocytic Leukemia
por: Reyhanoglu, Gizem, et al.
Publicado: (2020)

Ocular Symptom Can Be the First Presentation of Differentiation Syndrome in Acute Promyelocytic Leukemia
por: Gim, Yujin, et al.
Publicado: (2021)

Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge
por: Droc, Gabriela, et al.
Publicado: (2023)

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
por: Bernal, Teresa, et al.
Publicado: (2023)

Differentiation Syndrome in Promyelocytic Leukemia: Clinical Presentation, Pathogenesis and Treatment
por: Rego, E.M., et al.
Publicado: (2011)

Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome
por: Braun, Theodore P., et al.
Publicado: (2014)

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome
por: Yamamoto de Almeida, Luciana, et al.
Publicado: (2020)

Early death in acute promyelocytic leukemia: time to redefine risk groups
por: Salman, Meira Yisraeli, et al.
Publicado: (2022)

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia
por: Thomé, Carolina Hassibe, et al.
Publicado: (2020)

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review
por: Li, Wen-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_knjpuatmhsbrid38vb09gq5vhi